Burning Rock shares surge 14.96% intraday after passing four proficiency tests by NCCL and CAP, with high-throughput sequencing lab accredited 311 times consecutively.

Burning Rock surged 14.96% intraday, as the company announced it has passed four inter-laboratory quality assessment projects organized by the National Center for Clinical Laboratories (NCCL) and the College of American Pathologists (CAP). The company, which specializes in next-generation sequencing (NGS) for precision oncology, has had its high-throughput sequencing lab pass authoritative evaluations for 311 consecutive times. It focuses on developing precision cancer diagnostics to help clinicians create personalized treatment plans.